This report contains market size and forecasts of Cell Multiplex Assay Technology in Global, including the following market information:
Global Cell Multiplex Assay Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell Multiplex Assay Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Consumables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Multiplex Assay Technology include Luminex Corporation (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc (US), Bio-Rad Laboratories, Inc. (US), Qiagen N.V. (Netherlands), Abcam plc (UK), Becton, Dickinson and Company (US), Merck KGaA (Germany) and Agilent Technologies, Inc. (US), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell Multiplex Assay Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Multiplex Assay Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell Multiplex Assay Technology Market Segment Percentages, by Type, 2021 (%)
Consumables
Instruments
Software & Services
Global Cell Multiplex Assay Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cell Multiplex Assay Technology Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other
Global Cell Multiplex Assay Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cell Multiplex Assay Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Multiplex Assay Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cell Multiplex Assay Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Luminex Corporation (US)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc (US)
Bio-Rad Laboratories, Inc. (US)
Qiagen N.V. (Netherlands)
Abcam plc (UK)
Becton, Dickinson and Company (US)
Merck KGaA (Germany)
Agilent Technologies, Inc. (US)
Meso Scale Diagnostics (US)
Randox Laboratories (UK)
Quanterix (US)
Bio-Techne Corporation (US)
Olink (Sweden)
DiaSorin S.p.A. (Italy)
Seegene (South Korea)
Promega Corporation (US)
Siemens Healthineers (Germany)
PerkinElmer, Inc. (US)
Shimadzu Biotech (Japan)
Antigenix America, Inc. (US)
Enzo Life Sciences, Inc. (US)
Boster Biological Technology (US)
AYOXXA Biosystems GmbH (Germany)
Cayman Chemical Company (US)